Turning Point Brands (TPB) Makes Strategic Investment in Cannabis Brand dosist
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Turning Point Brands (TPB) PT Raised to $45 at Cowen
October 27, 2020 3:47 PM EDTCowen analyst Vivien Azer raised the price target on Turning Point Brands (NYSE: TPB) to $45.00 (from $39.00) while maintaining an Outperform rating following 'beat and raise' and deal to take a stake in dosist.
The analyst commented, "TPB delivered 3Q20 revenues which were ~$11... More
